The Antigua and Barbuda government has confirmed extensive internal discussions regarding the potential deployment of genetically modified (GM) mosquitoes as a novel strategy against vector-borne diseases. However, officials have declared the nation is not yet ready to implement this biotechnology solution, identifying significant barriers that must first be overcome.
During a recent post-Cabinet media briefing, Maurice Merchant, Director General of Communications in the Prime Minister’s Office, addressed inquiries about adopting more aggressive mosquito control methods. Merchant revealed that while the government has seriously evaluated GM mosquitoes, the approach remains under scrutiny with no immediate plans for implementation.
Public acceptance emerged as the primary concern, with Merchant emphasizing that comprehensive public education and community sensitization represent substantial challenges. The significant financial investment required for genetically modified initiatives presents another considerable obstacle, making cost-effectiveness a critical factor in the decision-making process.
The nation’s tropical climate further complicates potential deployment, creating environmental conditions particularly conducive to mosquito proliferation that may diminish the effectiveness of singular technological solutions.
Currently, the government continues to prioritize conventional mosquito control methodologies administered through the Central Board of Health’s vector-borne disease control division, which Merchant described as exceptionally effective. These established programs rely heavily on public participation in eradication efforts and community-level preventive measures.
Government officials indicated that innovative scientific approaches would only be reconsidered should existing conventional methods prove inadequate in addressing the persistent challenge of mosquito-borne illnesses in the Caribbean nation.